etrials partners with Eclipse Clinical Technologies
Under the terms of the agreement, Eclipse will provide European-based sales personnel, project management guidance and technical support to help etrials offer its electronic data capture (EDC) solution to European customers staging clinical trials.
According to the partnering companies the first client of this new partnership is a 6,000-patient clinical study for a major U.S.-based pharmaceutical company with 270 sites total including 50 European sites in seven countries. Under the terms of the agreement, Eclipse will provide technical support and services to the 50 European sites.
In addition, Eclipse revealed it has selected etrials as its preferred EDC vendor through a separate software licensing agreement. Under the terms of the separate agreement, etrials will provide Eclipse with EDC software that is designed to simplify data collection and speed up the clinical research process for healthcare, pharmaceutical and biotechnology companies worldwide.
"We selected etrials as our preferred EDC partner because the company offers the most reliable and scalable solution in the market," said Pascal King, CEO Eclipse Clinical Technologies. "etrials' technology coupled with our contract research services will enable us to satisfy the clinical research needs of European life sciences companies and help speed valuable medicines and devices through the European approval process."
"etrials is expanding our global sales and customer support capabilities, most recently marked by our technology deployment in one of the largest current international clinical trials with over 6,000 patients," said John Cline, President etrials. "The cornerstone of etrials' success has always been offering superior EDC technology with exceptional customer service to our clinical research customers. Our relationship with Eclipse allows etrials to offer the same high-quality level of customer service throughout Europe."